KARABELAS ARGERIS N — SEC Form 4 filings
SEC reporting owner CIK 1191229. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-02.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-04 to 2026-06-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 51,100 shares, $631,280 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 11,000 shares @ $15.04 ($165,495) in REGENXBIO Inc., filed 2024-07-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENXBIO Inc. (RGNX) | Director | 8 | — | 8 legs · 51,100 sh · $631,280 | 18 |
Form 4 filings — KARABELAS ARGERIS N
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-02 | 4 | REGENXBIO Inc. (RGNX) | Grant/award (A): 9,807 @ $0 · Grant/award (A): 46,600 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | REGENXBIO Inc. (RGNX) | Grant/award (A): 7,768 @ $0 · Grant/award (A): 39,815 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 10,000 @ $3.76 · Sale (S): 10,000 @ $10.11 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 10,000 @ $3.76 · Sale (S): 9,300 @ $11.50 · Sale (S): 700 @ $12.34 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 10,000 @ $3.76 · Option exercise (M): 100 @ $12.74 · Sale (S): 9,600 @ $13.45 · Sale (S): 400 @ $14.59 · Sale (S): 100 @ $15 · Option exercise (M): 100 (derivative) @ $0 · +1 more | EDGAR |
| 2024-07-30 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 11,000 @ $12.74 · Sale (S): 11,000 @ $15.04 · Option exercise (M): 11,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | REGENXBIO Inc. (RGNX) | Option exercise (M): 10,000 @ $3.76 · Sale (S): 10,000 @ $11.27 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | REGENXBIO Inc. (RGNX) | Grant/award (A): 4,790 @ $0 · Grant/award (A): 24,454 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1191229 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →